Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics, and Oxford Nanopore Technologies. Key findings are powered by ...

The technology-oriented Nasdaq 100 index is back into correction territory, down 10.5% after hitting an all-time high last ...

Manager Cathie Wood’s long-term mindset is admirable ... such as Intellia Therapeutics, 10x Genomics, CRISPR Therapeutics, and Teladoc. Based on our assessment of the fund’s People, Process ...

Manager Cathie Wood’s long-term mindset is admirable ... such as Intellia Therapeutics, 10x Genomics, CRISPR Therapeutics, and Teladoc. Based on our assessment of the fund’s People, Process ...

Tesla remained the largest holding of Cathie Wood’s flagship ARK Innovation ETF, accounting for 10% of the $5.8 billion assets by March 24(Bloomberg) Cathie Wood’s Ark Investment Management ...

Cathie Wood expects Tesla stock to hit a $2,600 high in five years — that's 10x its current share price. Her company Ark Investments continues to be a major investor in Elon Musk's electric ...

Ark Invest Chief Executive Officer Cathie Wood expects Tesla (TSLA, Financials) to reach $2,600 per share within five years, citing autonomous driving and robotaxis as the company's primary value ...

Cathie Wood, the star stock picker behind Tesla’s stratospheric valuation, has doubled down on her bets, citing the convergence of artificial intelligence (AI), new energy and automation for her ...

Given this risk, we thought we'd take a look at whether 10x Genomics (NASDAQ:TXG) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative ...

Cathie Wood has been quite polarizing on Wall Street. She’s the founder of ARK Invest, and this is a company that made bold bets during the post-COVID boom and delivered stellar returns back then.

Despite the challenging start to the 2025 trading year for Tesla (NASDAQ:TSLA) stock, Cathie Wood, one of the electric vehicle maker's most bullish investors, says her "outlook has not changed" on ...